Recent intensive studies of BAX/BAK shuttling, BCL-2 protein interactions and active BAX complexes have laid the foundation for developing novel strategies for cancer therapy and analyzing cellular susceptibility to apoptosis [26]. The gene discussed is BAX; the disease is cancer.